VANDELLI, Maria Angela
 Distribuzione geografica
Continente #
NA - Nord America 34.566
EU - Europa 17.489
AS - Asia 13.738
SA - Sud America 1.870
AF - Africa 254
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 28
Totale 67.995
Nazione #
US - Stati Uniti d'America 34.244
GB - Regno Unito 6.016
CN - Cina 4.707
IT - Italia 4.612
SG - Singapore 3.971
HK - Hong Kong 2.029
SE - Svezia 1.853
BR - Brasile 1.482
DE - Germania 1.137
TR - Turchia 773
RU - Federazione Russa 758
UA - Ucraina 747
VN - Vietnam 626
FI - Finlandia 541
KR - Corea 436
FR - Francia 414
BG - Bulgaria 295
IN - India 278
NL - Olanda 197
ID - Indonesia 157
CA - Canada 151
AR - Argentina 145
JP - Giappone 137
IE - Irlanda 123
RO - Romania 111
PL - Polonia 102
ZA - Sudafrica 102
BE - Belgio 96
MX - Messico 96
ES - Italia 93
BD - Bangladesh 80
EC - Ecuador 73
IQ - Iraq 73
PK - Pakistan 69
LT - Lituania 61
CH - Svizzera 58
IR - Iran 55
AT - Austria 50
CO - Colombia 45
AE - Emirati Arabi Uniti 44
AU - Australia 41
CZ - Repubblica Ceca 38
IL - Israele 36
MA - Marocco 36
MY - Malesia 36
UZ - Uzbekistan 35
EG - Egitto 34
CL - Cile 32
LU - Lussemburgo 31
VE - Venezuela 30
PT - Portogallo 27
PE - Perù 24
EU - Europa 23
GR - Grecia 22
SA - Arabia Saudita 22
PY - Paraguay 18
TW - Taiwan 18
TN - Tunisia 16
HU - Ungheria 15
MD - Moldavia 15
PH - Filippine 15
TH - Thailandia 15
DZ - Algeria 14
JO - Giordania 14
KZ - Kazakistan 14
AZ - Azerbaigian 12
KE - Kenya 12
UY - Uruguay 12
AL - Albania 11
JM - Giamaica 11
NO - Norvegia 11
DK - Danimarca 10
SN - Senegal 10
NP - Nepal 9
NZ - Nuova Zelanda 9
BO - Bolivia 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
OM - Oman 8
AM - Armenia 7
EE - Estonia 7
LA - Repubblica Popolare Democratica del Laos 7
LB - Libano 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
PA - Panama 6
RS - Serbia 6
SI - Slovenia 6
BH - Bahrain 5
BZ - Belize 5
GT - Guatemala 5
KH - Cambogia 5
LV - Lettonia 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
YE - Yemen 5
AN - Antille olandesi 4
ET - Etiopia 4
Totale 67.919
Città #
Southend 4.606
Santa Clara 3.372
Ashburn 2.853
Fairfield 2.820
Singapore 2.425
Chandler 2.167
Woodbridge 2.027
Hong Kong 2.011
Hefei 1.711
Jacksonville 1.531
Houston 1.407
Chicago 1.233
Seattle 1.199
Wilmington 1.171
Dearborn 1.131
Ann Arbor 1.073
Nyköping 1.028
Cambridge 951
Los Angeles 825
Beijing 797
London 767
Modena 643
Izmir 458
Salt Lake City 384
Seoul 358
New York 347
Princeton 313
Sofia 290
Council Bluffs 285
San Diego 267
Eugene 264
Dallas 254
The Dalles 243
Milan 242
Helsinki 235
Rome 218
Ho Chi Minh City 210
Bologna 204
Buffalo 204
Moscow 195
Redwood City 185
Des Moines 184
Shanghai 182
Elk Grove Village 165
Tampa 165
Munich 160
Hanoi 145
São Paulo 141
Bremen 124
Fremont 113
Jakarta 112
Dublin 105
Tokyo 101
Columbus 96
Reggio Emilia 93
Brussels 91
Lancaster 90
Frankfurt am Main 89
Falls Church 81
Boardman 80
Guangzhou 77
Miami 77
Sterling 75
Phoenix 73
San Jose 72
Naples 65
Parma 65
Atlanta 60
Warsaw 59
Johannesburg 56
Stockholm 56
Como 53
Dulles 53
Brooklyn 52
Nanjing 51
Chennai 50
Denver 49
Turku 49
Norwalk 48
Turin 47
Detroit 46
Kent 46
Orem 46
Florence 43
Kunming 41
Bari 39
Montreal 39
Redondo Beach 38
Tulare 38
Rio de Janeiro 36
Catania 35
Toronto 35
Milwaukee 34
Zhengzhou 34
Jinan 33
Napoli 33
Amsterdam 32
Changsha 32
San Francisco 32
Belo Horizonte 31
Totale 47.151
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 514
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 478
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 457
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 444
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 430
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 408
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 404
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 396
Cationic liposomes for gene transfection 393
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 392
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 389
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 389
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 385
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 383
The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions 383
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 382
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 379
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 377
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 371
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 370
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 369
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 366
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 366
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 361
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 356
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 351
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 350
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 349
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 347
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 345
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 340
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 336
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 331
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 329
Distribution of drugs in polymers loaded by swelling 328
Polymeric nanoparticles for the drug delivery to the central nervous system 326
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method 324
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 322
Brain targeting with polymeric nanoparticles: which administration route should we take? 320
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 320
A Metabolomic Approach Applied to a LiquidChromatography Coupled to High-ResolutionTandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the ComprehensiveEvaluation of the Chemical Composition ofCannabis Medicinal Extracts 320
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 316
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 315
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 314
Microwave-treated gelatin microspheres as drug delivery system 313
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 312
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 312
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 312
Nanoparticle transport across the blood brain barrier 308
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 302
Protein corona and nanoparticles: How can we investigate on? 302
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 301
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 301
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 299
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 298
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 298
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 297
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 294
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 294
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 292
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 291
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 287
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 286
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 286
Pharmaceutical and biomedical analysis of cannabinoids: A critical review 284
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 283
Bead coating process via an excess of crosslinking agent 282
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 282
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 281
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 279
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 278
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 278
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 277
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 277
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 277
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 277
Properties of tolmetin-loaded Eudragit RL100 and Eudragit RS100 microparticles prepared by different techniques 272
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 272
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 271
Colloidal systems for CNS drug delivery 270
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 268
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 268
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 268
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 268
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 267
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 266
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 263
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 261
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 260
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 260
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 259
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 258
Functionalization of liposomes: microscopical methods for preformulative screening 258
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 258
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 255
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 254
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 253
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 253
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 251
Solid state transitions and CAP availability in surface solid dispersions of chloramphenicol stearate polymorphs 250
Totale 31.848
Categoria #
all - tutte 268.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 268.004


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.168 0 0 0 0 0 458 599 865 315 1.107 454 370
2021/20225.454 242 633 533 395 201 251 288 344 626 403 891 647
2022/20236.359 751 688 500 621 732 933 171 561 734 117 244 307
2023/20244.469 224 264 273 353 912 463 524 576 161 139 209 371
2024/202513.981 758 200 301 1.052 2.683 1.898 1.053 923 1.353 529 1.477 1.754
2025/202614.384 1.679 978 2.015 3.195 4.773 1.744 0 0 0 0 0 0
Totale 68.485